Literature DB >> 33049207

Driving the Improvement of Lung Cancer Prognosis.

Wenhua Liang1, Jun Liu1, Jianxing He2.   

Abstract

An article in the New England Journal of Medicine reveals a significant reduction of incidence-based mortality of non-small cell lung cancer in the U.S. and attributes this improvement to the approval of targeted therapies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID： 33049207     DOI： 10.1016/j.ccell.2020.09.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  7 in total

1.  A Novel and Automated Approach to Classify Radiation Induced Lung Tissue Damage on CT Scans.

Authors:  Adam Szmul; Edward Chandy; Catarina Veiga; Joseph Jacob; Alkisti Stavropoulou; David Landau; Crispin T Hiley; Jamie R McClelland
Journal:  Cancers (Basel)       Date:  2022-03-05       Impact factor: 6.639

2.  LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer via Mediating miR-137/E2F7 Axis.

Authors:  Guang-Yin Zhao; Zhao-Feng Ning; Rui Wang
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 3.  KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.

Authors:  Juan Esteban Garcia-Robledo; Rafael Rosell; Alejandro Ruíz-Patiño; Carolina Sotelo; Oscar Arrieta; Lucia Zatarain-Barrón; Camila Ordoñez; Elvira Jaller; Leonardo Rojas; Alessandro Russo; Diego de Miguel-Pérez; Christian Rolfo; Andrés F Cardona
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 4.031

Review 4.  Advances in lung cancer screening and early detection.

Authors:  Caichen Li; Huiting Wang; Yu Jiang; Wenhai Fu; Xiwen Liu; Ran Zhong; Bo Cheng; Feng Zhu; Yang Xiang; Jianxing He; Wenhua Liang
Journal:  Cancer Biol Med       Date:  2022-05-11       Impact factor: 5.347

5.  The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492.

Authors:  Linwen Zhu; Lebo Sun; Guodong Xu; Jie Song; Bingchuan Hu; Zhongjie Fang; Yanggang Dan; Ni Li; Guofeng Shao
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

6.  Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).

Authors:  Yi Li; Xiaojuan Yang; Dan Lu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.

Authors:  Yimeng Cui; Xin Wang; Lei Zhang; Wei Liu; Jinfeng Ning; Ruixue Gu; Yaowen Cui; Li Cai; Ying Xing
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.